Announced details
Specialty fields such as thyroid care and obstetrics and gynecology
Voting rights ownership ratio increased from 21% to 30% (an increase of 9 percentage points)
We are an equity-method affiliate of FTS. Our voting rights ownership ratio was 21% before the additional investment and is 30% after the additional investment. The disclosure states that, before the additional investment, there were no applicable capital, personnel or business relationships with FTS.
FTS is a holding company that owns 100% of MEDCHOICE PHARMA HOLDINGS, INC. in the Philippines. Address: 201 Dingalan St., Ayala Alabang, Muntinlupa City. Representative: Chairman Ambrosio V. Padilla III. Capital: PHP 1.8 million (¥4.6 million). Established: 27 October 2003. MC's consolidated net sales for the fiscal year ended December 2024 were ¥2,900 million, and net income was ¥734 million.
201 Dingalan St., Ayala Alabang, Muntinlupa City
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Collaboration in the fields of thyroid care and obstetrics and gynecology |
| Counterparty | FTS AMBROSE HOLDINGS, INC.; MEDCHOICE PHARMA HOLDINGS, INC. |
| Counterparty overview | FTS is a holding company that owns 100% of MEDCHOICE PHARMA HOLDINGS, INC. in the Philippines. Address: 201 Dingalan St., Ayala Alabang, Muntinlupa City. Representative: Chairman Ambrosio V. Padilla III. Capital: PHP 1.8 million (¥4.6 million). Established: 27 October 2003. MC's consolidated net sales for the fiscal year ended December 2024 were ¥2,900 million, and net income was ¥734 million. |
| Relationship with the Company | We are an equity-method affiliate of FTS. Our voting rights ownership ratio was 21% before the additional investment and is 30% after the additional investment. The disclosure states that, before the additional investment, there were no applicable capital, personnel or business relationships with FTS. |
| Launch date | 14 April 2026 (date the additional investment was made; actual result) |
| Applicable area | Specialty fields such as thyroid care and obstetrics and gynecology |
| Location | 201 Dingalan St., Ayala Alabang, Muntinlupa City |
| Quantitative Effects | Voting rights ownership ratio increased from 21% to 30% (an increase of 9 percentage points) |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To strengthen our partnership with MEDCHOICE PHARMA HOLDINGS, INC., a subsidiary of FTS, pursue synergies through collaboration in specialty fields such as thyroid care and obstetrics and gynecology, and develop our global business.